Farnesyltransferase inhibitor
    1.
    发明授权
    Farnesyltransferase inhibitor 失效
    法呢基转移酶抑制剂

    公开(公告)号:US5925641A

    公开(公告)日:1999-07-20

    申请号:US912870

    申请日:1997-08-19

    摘要: The present invention relates to a farnesyltransferase inhibitor and an antitumor agent comprising, as an active ingredient, a piperazinedione derivative represented by formula (I): ##STR1## wherein R.sup.1 and R.sup.2 independently represent lower alkyl, lower alkoxyalkyl, substituted or unsubstituted aryl, or aralkyl; R.sup.3 and R.sup.4 independently represent mercapto, lower alkanoylthio, aroylthio, lower alkoxycarbonylthio, or aryloxycarbonylthio, or alternatively R.sup.3 and R.sup.4 are combined together to form disulfide; and R.sup.5 and R.sup.6 independently represent hydrogen, lower alkyl, lower alkoxyalkyl, hydroxyalkyl, lower alkanoyloxyalkyl, aroyloxyalkyl, aralkyloxyalkyl, or aralkyl.

    摘要翻译: 本发明涉及法呢基转移酶抑制剂和抗肿瘤剂,其包含作为活性成分的由式(I)表示的哌嗪二酮衍生物:其中R1和R2独立地表示低级烷基,低级烷氧基烷基,取代或未取代的芳基或芳烷基; R3和R4独立地表示巯基,低级烷酰硫基,芳酰硫基,低级烷氧基羰基硫基或芳氧基羰基硫基,或者R3和R4组合在一起形成二硫化物; R 5和R 6独立地表示氢,低级烷基,低级烷氧基烷基,羟烷基,低级烷酰氧基烷基,芳氧基烷基,芳烷氧基烷基或芳烷基。

    Farnesyltransferase inhibitor
    2.
    发明授权
    Farnesyltransferase inhibitor 失效
    法呢基转移酶抑制剂

    公开(公告)号:US5728830A

    公开(公告)日:1998-03-17

    申请号:US436458

    申请日:1995-05-22

    摘要: The present invention relates to a farnesyltransferase inhibitor and an antitumor agent comprising, as an active ingredient, a piperazinedione derivative represented by formula (I): ##STR1## wherein R.sup.1 and R.sup.2 independently represent lower alkyl, lower alkoxyalkyl, substituted or unsubstituted aryl, or aralkyl; R.sup.3 and R.sup.4 independently represent mercapto, lower alkanoylthio, aroylthio, lower alkoxycarbonylthio, or aryloxycarbonylthio, or alternatively R.sup.3 and R.sup.4 are combined together to form disulfide; and R.sup.5 and R.sup.6 independently represent hydrogen, lower alkyl, lower alkoxyalkyl, hydroxyalkyl, lower alkanoyloxyalkyl, aroyloxyalkyl, aralkyloxyalkyl, or aralkyl.

    摘要翻译: PCT No.PCT / JP94 / 01543 Sec。 371日期:1995年5月22日 102(e)日期1995年5月22日PCT 1994年9月20日PCT公布。 出版物WO95 / 08542 日期:1995年3月30日本发明涉及法呢基转移酶抑制剂和抗肿瘤剂,其包含作为活性成分的式(I)表示的哌嗪二酮衍生物:其中R 1和R 2独立地表示低级烷基,低级 烷氧基烷基,取代或未取代的芳基或芳烷基; R3和R4独立地表示巯基,低级烷酰硫基,芳酰硫基,低级烷氧基羰基硫基或芳氧基羰基硫基,或者R3和R4组合在一起形成二硫化物; R 5和R 6独立地表示氢,低级烷基,低级烷氧基烷基,羟烷基,低级烷酰氧基烷基,芳氧基烷基,芳烷氧基烷基或芳烷基。

    Epoxycyclohexenedione derivatives
    3.
    发明授权
    Epoxycyclohexenedione derivatives 失效
    环氧环己烯二酮衍生物

    公开(公告)号:US5565489A

    公开(公告)日:1996-10-15

    申请号:US436359

    申请日:1995-05-18

    CPC分类号: C07D303/36

    摘要: The present invention relates to an epoxycyclohexenedione derivative represented by formula (I): ##STR1## wherein R is a straight-chain or branched alkanoyl group having 10 to 25 carbon atoms, a straight-chain alkenoyl group having 10 to 25 carbon atoms, or a group represented by formula (A): ##STR2## wherein n is an integer of 1 to 4; or a pharmaceutically acceptable salt thereof.The compounds exhibit antimicrobial activity and antitumor activity.

    摘要翻译: PCT No.PCT / JP94 / 01542 Sec。 371日期1995年5月18日 102(e)日期1995年5月18日PCT 1994年9月20日PCT公布。 公开号WO95 / 08546 日期:1995年3月30日本发明涉及式(I)表示的环氧环己烯二酮衍生物:其中R为碳原子数为10〜25的直链或支链烷酰基,直链烯酰基 具有10至25个碳原子,或由式(A)表示的基团:其中n为1至4的整数; 或其药学上可接受的盐。 该化合物表现出抗微生物活性和抗肿瘤活性。

    Sh3 domain binding inhibitors
    7.
    发明申请
    Sh3 domain binding inhibitors 审中-公开
    Sh3结构域结合抑制剂

    公开(公告)号:US20050069999A1

    公开(公告)日:2005-03-31

    申请号:US10483439

    申请日:2002-04-19

    IPC分类号: C12N9/99

    摘要: The present invention provides SH3 domain binding inhibitors comprising, as an active ingredient, a non-peptide compound exhibiting SH3 domain binding inhibitory activity, a low molecular weight compound with molecular weight less than 750 which exhibit SH3 domain binding inhibitory activity, in particular, a compound represented by the general formula (I) or (II) described above, a cytochalsin, etc., or pharmaceutically acceptable salts thereof. The present invention also provides compounds represented by the general formula (Va), (Vb) or (VI) described above or pharmaceutically acceptable salts thereof.

    摘要翻译: 本发明提供SH3结构域结合抑制剂,其包含作为活性成分的表现SH3结构域结合抑制活性的非肽化合物,分子量小于750的低分子量化合物,其表现出SH3结构域结合抑制活性,特别是 由上述通式(I)或(II)表示的化合物,细胞松弛素等,或其药学上可接受的盐。 本发明还提供由上述通式(Va),(Vb)或(VI)表示的化合物或其药学上可接受的盐。

    Radio apparatus
    10.
    发明申请
    Radio apparatus 审中-公开
    无线电设备

    公开(公告)号:US20060262931A1

    公开(公告)日:2006-11-23

    申请号:US10569352

    申请日:2003-10-29

    申请人: Hirofumi Nakano

    发明人: Hirofumi Nakano

    IPC分类号: H04K1/00

    摘要: A radio apparatus encrypts transmission information to be radio-transmitted at a radio station or decrypts transmission information received through a radio transmission path. The radio apparatus securely encrypts, for transmission, information containing information to be encrypted. Thus, the radio apparatus includes an encryption object identifying unit which identifies from transmission information a portion whose contents and/or attributes that satisfy predetermined conditions, and a transmitting unit which encrypts the identified portion of the transmission information or information containing the identified portion and which radio-transmits the encryption result.

    摘要翻译: 无线装置对通过无线电台进行无线发送的发送信息进行加密,对通过无线传输路径接收的发送信息进行解密。 无线电设备安全地加密用于传输的包含要加密的信息的信息。 因此,无线电设备包括:加密对象识别单元,其从传输信息识别满足预定条件的内容和/或属性的部分;以及发送单元,其对发送信息的识别部分或包含所识别部分的信息进行加密,以及哪个 无线电传输加密结果。